We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+20.94%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$612B
AUM Growth
+$90.2B
Cap. Flow
-$9.31B
Cap. Flow %
-1.52%
Top 10 Hldgs %
32.09%
Holding
12,204
New
1,722
Increased
4,580
Reduced
4,534
Closed
1,264

Top Sells

Rank Stock Value
1
C icon
Citigroup
C
+$703M
2
BAC icon
Bank of America
BAC
+$690M
3
AMZN icon
Amazon
AMZN
+$678M
4
JPM icon
JPMorgan Chase
JPM
+$601M
5
META icon
Meta Platforms (Facebook)
META
+$431M

Sector Composition

Rank Sector Weight
1 Technology 2.38%
2 Consumer Discretionary 1.48%
3 Healthcare 0.92%
4 Communication Services 0.78%
5 Financials 0.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTE icon
10851
Gran Tierra Energy
GTE
$351M
$9K ﹤0.01%
+2,426
New +$6.53K
TTI icon
10852
CALL
TETRA Technologies
TTI
$1.01B
$9K ﹤0.01%
+10,100
New +$6.93K
ADILW
10853
DELISTED
Adial Pharmaceuticals Warrant
ADILW
$8K ﹤0.01%
+21,686
New +$7.29K
ASRT
10854
CALL
DELISTED
Assertio
ASRT
$7K ﹤0.01%
315
-1,780
-85% -$55.3K
ARTLW
10855
DELISTED
Artelo Biosciences, Inc. Warrant
ARTLW
$7K ﹤0.01%
28,333
+2,891
+11% +$328
AAU
10856
CALL
DELISTED
Almaden Minerals Ltd
AAU
$7K ﹤0.01%
+15,000
New +$13.1K
NSPRZ
10857
DELISTED
InspireMD, Inc. Series B Warrants
NSPRZ
$7K ﹤0.01%
527,534
-126,531
-19% -$1.62K
CPHI icon
10858
China Pharma Holdings
CPHI
$39.8M
$6K ﹤0.01%
+28
New +$6.02K
SXTC icon
10859
China SXT Pharmaceuticals
SXTC
$1.95M
0
TOVX icon
10860
Theriva Biologics
TOVX
$11.1M
$6K ﹤0.01%
+63
New +$5.52K
PAVMW
10861
DELISTED
PAVmed Inc. Warrant
PAVMW
$6K ﹤0.01%
+14,078
New +$10.5K
ONTXW
10862
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
$6K ﹤0.01%
58,674
+47,998
+450% +$2.97K
GHSI
10863
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$5K ﹤0.01%
+38
New +$2.65K
APOPW
10864
DELISTED
Cellect Biotechnology Ltd. Warrants to Purchase ADRs
APOPW
$5K ﹤0.01%
28,500
+8,740
+44% +$1.47K
GSAT icon
10865
PUT
Globalstar
GSAT
$10.6B
$4K ﹤0.01%
847
-806
-49% -$3.9K
HOFVW
10866
DELISTED
Hall of Fame Resort & Entertainment Company Warrant
HOFVW
$3K ﹤0.01%
+12,033
New +$3.3K
TDW.WS
10867
DELISTED
Tidewater Inc.
TDW.WS
$3K ﹤0.01%
+10,879
New +$3.25K
THWWW
10868
DELISTED
Target Hospitality Corp. Warrant expiring 3/15/2024
THWWW
$3K ﹤0.01%
46,600
CETXW
10869
DELISTED
Cemtrex Inc. Series 1 Warrant
CETXW
$2K ﹤0.01%
+17,512
New +$1.3K
SHIPW
10870
DELISTED
Seanergy Maritime Holdings Corp Class A Warrants
SHIPW
$2K ﹤0.01%
62,094
-170,174
-73% -$4.37K
LGHLW
10871
DELISTED
Lion Group Holding Ltd. Warrant
LGHLW
$1K ﹤0.01%
+11,281
New +$1.03K
AADR icon
10872
AdvisorShares Dorsey Wright ADR ETF
AADR
$39.3M
-23,235
Closed -$1.28M
ACEL icon
10873
PUT
Accel Entertainment
ACEL
$966M
-17,600
Closed -$188K
ACRE
10874
PUT
Ares Commercial Real Estate
ACRE
$259M
-37,800
Closed -$345K
ACRS icon
10875
CALL
Aclaris Therapeutics
ACRS
$921M
-11,900
Closed -$31K

Similar funds

Jeff Yass's Q4 2020 Portfolio in Review

As of Q4 2020, Jeff Yass held 12,204 positions worth $612B, up 17% from $522B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q4 2020 filing shows 1,722 new, 4,580 increased, 4,534 reduced and 1,264 closed positions. Its largest new stake was International Flavors & Fragrances: 726,729 shares worth $79.1M. The largest sale was Citigroup, an estimated $703M.

By sector, the portfolio is most concentrated in Technology at 2.4% of assets, up from 2% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Jeff Yass's largest Q4 2020 buy was International Flavors & Fragrances: 726,729 shares worth $79.1M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $1.46B increase.
  • Jeff Yass's biggest Q4 2020 reduction was Citigroup, cutting an estimated $703M.
  • Jeff Yass fully exited Vanguard Total International Bond ETF in Q4 2020, selling an estimated $146M.
  • Jeff Yass's ten largest holdings make up 32% of its $612B portfolio in Q4 2020.
  • Jeff Yass opened 1,722 new positions and closed 1,264 in Q4 2020.
  • Jeff Yass's portfolio value rose 17% quarter-over-quarter to $612B.

Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.